Siegel Todd E

Pres., CEO, COB at MTS MEDICATION TECHNOLOGIES, INC /DE/

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
4
Latest Dec 22, 2009
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
2
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Dec 22, 2009Unusual

    MTS MEDICATION TECHNOLOGIES, INC /DE/

    Sold 62.3% of their holdings

    1M shares

    Filed Dec 22, 2009Form 4

  2. Nov 13, 2007Unusual

    MTS MEDICATION TECHNOLOGIES, INC /DE/

    Sold 50.6% of their holdings

    $800k60,000 shares at $13.34

    Filed Nov 15, 2007Form 4

  3. Feb 23, 2007Plan not stated

    MTS MEDICATION TECHNOLOGIES, INC /DE/

    Sold 2.4% of their holdings

    $417k39,590 shares at $10.54

    Filed Feb 26, 2007Form 4

  4. Feb 21, 2007Plan not stated

    MTS MEDICATION TECHNOLOGIES, INC /DE/

    Sold 1.2% of their holdings

    $217k20,410 shares at $10.61

    Filed Feb 22, 2007Form 4

4 of 4

Every transaction

Every transaction on a Form 4 or Form 5 by Siegel Todd E
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jun 1, 2026Jun 3, 2026OMEXDirectorExercised or settledRestricted Stock Unit (RSU)20,0000SEC
Jun 1, 2026Jun 3, 2026OMEXDirectorExercised options20,000166,377SEC
May 7, 2026May 11, 2026SGCDirectorAwarded9,58375,607SEC
Apr 20, 2026Apr 22, 2026OMEXDirectorAwarded31,475146,377SEC
Feb 6, 2026Feb 10, 2026OMEXDirectorAwarded7,937114,902SEC
Jan 6, 2026Jan 8, 2026OMEXDirectorAwarded7,653106,965SEC
Dec 5, 2025Dec 9, 2025OMEXDirectorAwarded7,28299,312SEC
Dec 2, 2025Dec 4, 2025OMEXDirectorAwardedRestricted Stock Unit (RSU)50,00030,000SEC
Nov 6, 2025Nov 10, 2025OMEXDirectorAwarded7,04292,030SEC
Jul 1, 2025Jul 2, 2025SGCDirectorAwarded8,84566,024SEC
Apr 14, 2025Apr 15, 2025OMEXDirectorAwarded28,08384,988SEC
Nov 14, 2024Nov 18, 2024OMEXDirectorAwardedStock Option (Right to Buy)30,00030,000SEC
Oct 23, 2024Nov 13, 2024OMEXDirectorAwarded13,95456,905SEC
May 9, 2024May 10, 2024SGCDirectorAwardedNQ Stock Options2,750$19.91$55k2,750SEC
May 9, 2024May 10, 2024SGCDirectorAwarded3,76657,719SEC
Apr 8, 2024Apr 10, 2024OMEXDirectorAwarded2,95342,951SEC
Jan 29, 2024Jan 31, 2024OMEXDirectorAwardedStock Option (Right to Buy)30,00030,000SEC
Nov 30, 2023Dec 4, 2023OMEXDirectorAwarded3,16039,998SEC
Nov 8, 2023Nov 9, 2023SGCDirectorAwarded7,53753,413SEC
Jun 9, 2023Jun 13, 2023OMEXDirectorAwarded5,31136,838SEC
May 24, 2023May 26, 2023OMEXDirectorAwardedStock Option(Right to Buy)6,5416,541SEC
May 12, 2023May 16, 2023SGCDirectorAwardedNQ Stock Options2,750$8.33$23k2,750SEC
Jan 17, 2023Jan 19, 2023OMEXDirectorAwarded10,24531,527SEC
Nov 28, 2022Nov 29, 2022SGCDirectorBought5,000$10.50$53k45,876SEC
Nov 4, 2022Nov 7, 2022SGCDirectorAwarded6,90940,876SEC
Sep 30, 2022Oct 4, 2022OMEXDirectorAwarded4,43521,282SEC
Jun 30, 2022Jul 5, 2022OMEXDirectorAwarded3,29916,847SEC
May 13, 2022May 16, 2022SGCDirectorAwardedNQ Stock Options2,750$16.18$44k2,750SEC
Mar 31, 2022Apr 4, 2022OMEXDirectorAwarded2,36513,548SEC
Jan 19, 2022Jan 21, 2022OMEXDirectorAwarded7,93311,183SEC
Nov 11, 2021Nov 15, 2021SGCDirectorAwarded2,73333,967SEC
May 14, 2021May 18, 2021SGCDirectorAwardedNQ Stock Options2,750$26.13$72k2,750SEC
Nov 6, 2020Nov 10, 2020SGCDirectorAwarded3,36431,178SEC
May 12, 2020May 13, 2020SGCDirectorAwardedNQ Stock Options5,425$8.48$46k2,675SEC
Nov 1, 2019Nov 5, 2019SGCDirectorAwarded3,94327,814SEC
May 3, 2019May 7, 2019SGCDirectorAwardedNQ Stock Options2,750$16.84$46k2,750SEC
Nov 2, 2018Nov 6, 2018SGCDirectorAwarded3,06423,871SEC
May 3, 2018May 7, 2018SGCDirectorAwardedNQ Stock Options2,750$24.28$67k2,750SEC
Nov 1, 2017Nov 2, 2017SGCDirectorAwarded2,13820,807SEC
May 5, 2017May 15, 2017SGCDirectorAwardedNQ Stock Options2,750$18.05$50k2,750SEC
Nov 4, 2016Nov 7, 2016SGCDirectorAwarded2,446$16.35$40k18,669SEC
May 6, 2016May 9, 2016SGCDirectorAwardedNQ Stock Options2,750$18.55$51k2,750SEC
Nov 6, 2015Nov 10, 2015SGCDirectorAwarded1,819$17.59$32k16,223SEC
Aug 31, 2015Sep 1, 2015SGCDirectorBought2,900$17.14$50k14,404SEC
May 1, 2015May 4, 2015SGCDirectorAwardedNQ Stock Options2,750$16.78$46k2,750SEC
Nov 7, 2014Nov 10, 2014SGCDirectorAwarded7525,752SEC
May 12, 2014May 14, 2014SGCDirectorBought5,000$16.14$81k5,000SEC
May 2, 2014May 5, 2014SGCDirectorAwardedCommon Shares3,500$15.91$56k3,500SEC
Dec 22, 2009Dec 22, 2009MTS MEDICATION TECHNOLOGIES, INC /DE/Pres., CEO, COBSold1M606,125SEC
Dec 22, 2009Dec 22, 2009MTS MEDICATION TECHNOLOGIES, INC /DE/Pres., CEO, COBReturned to the companyOptions (right to buy)56,7770SEC
Page 1

Sales and notices (4)

Form 144 notices and Form 4 sales by Siegel Todd E
Source
Dec 22, 2009Dec 22, 2009MTS MEDICATION TECHNOLOGIES, INC /DE/Pres., CEO, COBForm 4 sale1M62.3%UnusualSEC
Nov 13, 2007Nov 15, 2007MTS MEDICATION TECHNOLOGIES, INC /DE/Pres. CEO COBForm 4 sale60,000$800k50.6%UnusualSEC
Feb 23, 2007Feb 26, 2007MTS MEDICATION TECHNOLOGIES, INC /DE/Pres. CEO, COBForm 4 sale39,590$417k2.4%Plan not statedSEC
Feb 21, 2007Feb 22, 2007MTS MEDICATION TECHNOLOGIES, INC /DE/Pres. CEO, COBForm 4 sale20,410$217k1.2%Plan not statedSEC